BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22178570)

  • 1. Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus.
    Chak A; Chen Y; Vengoechea J; Canto MI; Elston R; Falk GW; Grady WM; Guda K; Kinnard M; Markowitz S; Mittal S; Prasad G; Shaheen N; Willis JE; Barnholtz-Sloan JS
    Cancer Epidemiol Biomarkers Prev; 2012 Feb; 21(2):376-83. PubMed ID: 22178570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Barrett's esophagus in relatives by endoscopic screening.
    Chak A; Faulx A; Kinnard M; Brock W; Willis J; Wiesner GL; Parrado AR; Goddard KA
    Am J Gastroenterol; 2004 Nov; 99(11):2107-14. PubMed ID: 15554988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age of diagnosis in familial Barrett's associated neoplasia.
    Glamour BK; Alaber O; Cioffi G; Chandar AK; Barnholtz-Sloan J; Brock W; Falk GW; Canto MI; Wang JS; Iyer PG; Shaheen NJ; Grady WM; Abrams JA; Thota PN; Chak A; Blum AE
    Fam Cancer; 2022 Jan; 21(1):115-120. PubMed ID: 33694069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of endoscopic and clinical characteristics of patients with familial and sporadic Barrett's esophagus.
    Ash S; Vaccaro BJ; Dabney MK; Chung WK; Lightdale CJ; Abrams JA
    Dig Dis Sci; 2011 Jun; 56(6):1702-6. PubMed ID: 21347561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
    Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
    Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial clustering of Barrett's esophagus and esophageal adenocarcinoma in a European cohort.
    Verbeek RE; Spittuler LF; Peute A; van Oijen MG; Ten Kate FJ; Vermeijden JR; Oberndorff A; van Baal JW; Siersema PD
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1656-63.e1. PubMed ID: 24480679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.
    Chak A; Ochs-Balcom H; Falk G; Grady WM; Kinnard M; Willis JE; Elston R; Eng C
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of young patients with early Barrett's neoplasia.
    Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
    World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium.
    Desai M; Lieberman DA; Kennedy KF; Hamade N; Thota P; Parasa S; Gorrepati VS; Bansal A; Gupta N; Gaddam S; Young PE; Mathur S; Moawad FJ; Cash BD; Sampliner R; Vargo JJ; Falk GW; Sharma P
    Gastrointest Endosc; 2019 Feb; 89(2):257-263.e3. PubMed ID: 30342028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction.
    Chak A; Falk G; Grady WM; Kinnard M; Elston R; Mittal S; King JF; Willis JE; Kondru A; Brock W; Barnholtz-Sloan J
    Am J Gastroenterol; 2009 Aug; 104(8):1913-21. PubMed ID: 19491834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
    Kamboj AK; Katzka DA; Iyer PG
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.
    Thota PN; Vennalaganti P; Vennelaganti S; Young P; Gaddam S; Gupta N; Lieberman D; Sampliner R; Falk GW; Mathur S; Kennedy K; Cash BD; Moawad F; Bansal A; Spaander MC; Bruno MJ; Vargo J; Sharma P
    Gastroenterology; 2017 Apr; 152(5):987-992. PubMed ID: 27988383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and staging of esophageal cancers within Barrett's esophagus is improved by assessment in specialized Barrett's units.
    Cameron GR; Jayasekera CS; Williams R; Macrae FA; Desmond PV; Taylor AC
    Gastrointest Endosc; 2014 Dec; 80(6):971-83.e1. PubMed ID: 24929493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
    Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
    Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of extra-esophageal cancers in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Talukdar A; Chak A; Lee T; Fang X; Watson P; Lynch H; Mittal S
    Trop Gastroenterol; 2012; 33(3):185-8. PubMed ID: 23600048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
    Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of patients with long-segment Barrett's esophagus: A multicenter prospective cohort study in Japan.
    Matsuhashi N; Sakai E; Ohata K; Ishimura N; Fujisaki J; Shimizu T; Iijima K; Koike T; Endo T; Kikuchi T; Inayoshi T; Amano Y; Furuta T; Haruma K; Kinoshita Y
    J Gastroenterol Hepatol; 2017 Feb; 32(2):409-414. PubMed ID: 27416773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study.
    Visrodia K; Iyer PG; Schleck CD; Zinsmeister AR; Katzka DA
    Dig Dis Sci; 2016 Jan; 61(1):158-67. PubMed ID: 25956705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.